Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study

This publication has 43 references indexed in Scilit:

• Expression of the Angiogenic Protein, Platelet-Derived Endothelial Cell Growth Factor, in Coronary Atherosclerotic Plaques
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: Insight into ischemia-induced reduction in endothelium-dependent vasodilatation
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Arterial gene therapy
  The Lancet, 1996
• Echo Planar MRI of the Heart on a Standard System: Validation of Measurements of Left Ventricular Function and Mass
  Journal of Computer Assisted Tomography, 1996
• Heparin Structure and Interactions with Basic Fibroblast Growth Factor
  Science, 1996
• Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury
  Molecular and Cellular Biochemistry, 1995
• Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
  Journal of the American College of Cardiology, 1993
• Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985–1986 NHLBI PTCA Registry)
  The American Journal of Cardiology, 1992
• Hypotensive Activity of Fibroblast Growth Factor
  Science, 1991
• The effect of complete and incomplete revascularization on exercise variables in patients undergoing coronary angioplasty
  Clinical Cardiology, 1990